Clinical Trial Update: Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety of combining brain radiotherapy with bevacizumab (Avastin) for brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Metastatic Malignant Neoplasm to Brain | Phase 1 | Status: COMPLETED